Efficacy of immunotherapy for treatment of allergic asthma in children

Allergy and Asthma Proceedings

Volumn 31, Issue 4, 2010, Pages 324-330

  Alzakar, Riyadh H ^a   Alsamarai, Abdulghani Mohamad ^b  

^a UNIVERSITY OF BASRAH   (Iraq)

^b TIKRIT UNIVERSITY   (Iraq)

Author keywords

Asthma; Children; Immunotherapy; Pharmacotherapy; Primary school; Subcutaneous immunotherapy

Indexed keywords

ALLERGEN; AMINOPHYLLINE; BECLOMETASONE; IMMUNOGLOBULIN E;

ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIZATION; SINGLE BLIND PROCEDURE;

AMINOPHYLLINE; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; MALE; TREATMENT OUTCOME;

EID: 77956304672     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3353     Document Type: Article

References (52)

1. Mannino DM, Homa DM, Akinobami LJ, et al. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 51: 1-13, 2002.
2. Chesnutt MS and Prendergast TJ. Common manifestations of lung disease. In Current Medical Diagnosis and Treatment. Tierney LM Jr, Macphee SJ, Papadakis MA (Eds). 40th ed., New York: McGraw-Hill 215, 2007.
3. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 120:S25-S85, 2007.
4. Schmidt-Weber CB, and Blaser K. New insights into mechanisms of allergen-specific immnuotherapy. Curr Opin Allergy Clin Immunol 5:525-530, 2005. (Pubitemid 41679988)
5. Jerzynska J, Stelmach W, Majak P, et al. Effect of specific immunotherapy on serum levels of tumour necrosis factor alpha in asthmatic children. Allergy Asthma Proc 29:274-279, 2008.
6. Cox L. Allergen immunotherapy and asthma: Efficacy, safety, and others considerations. Allergy Asthma Proc 29:580-589, 2008.
7. Finegold I. Immunotherapy: When to initiate treatment in children. Allergy Asthma Proc 28:698-705, 2007.
8. Ariano R, Berto P, Tracci D, et al. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc 27:159-163, 2006. (Pubitemid 43700869)
9. Bousquet J, LockeyR, and MallingHJ. World Health Organization Position Paper. Allergen Immunotherapy: Therapeutical vaccines for allergic diseases. Allergy 53:112-121, 1998.
10. Till SJ, Francis JN, Nouri-Aria K, and Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 113:1025-1034, 2004.
11. Bousquet J, Vignola AM, Campbell AM, and Michel FB. Pathophysiology of allergic rhinitis. Int Allergy Immunol 110:207-218, 1996.
12. Boulay ME, and Boulet LP. Lower airway inflammatory responses to repeated very-low-dose allergen challenge in allergic rhinitis and asthma. Clin Exp Allergy 32:1441-1447, 2002.
13. Lockey RF. ARIA. Global guidelines and new forms of allergen immunotherapy. J Allergy Clin Immunol 108:497-499, 2001.
14. Bousquet J, Lockey R, and Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102:558-562, 1998.
15. Spergel JM, and Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112(suppl 6):S128-S139, 2003.
16. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis. J Allergy Clin Immunol 109:251-256, 2002. (Pubitemid 34158289)
17. Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen specific immunotherapy: A randomized, placebo-controlled, double-blind, double-dummy study. Allergy 59:45-53, 2004. (Pubitemid 38167951)
18. Des-Roches A, Paradis L, Menardo J, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitization in children. J Allergy Clin Immunol 99:450-453, 1997. (Pubitemid 27173080)
19. Pajno G, Barberio G, Deluca F, et al. Prevention of new sensitization in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31:1392-1397, 2001. (Pubitemid 32823876)
20. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass pollen immunotherapy. N Eng J Med 341:468-475, 1999. (Pubitemid 29372886)
21. Eng PA, Reinhold M, and Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 57:306-312, 2002. (Pubitemid 34280657)
22. Alsamarai AGM, Alwan AM, Ahmad AH, et al. The relationship between asthma and allergic rhinitis in the Iraqi population. Allergol Int 58:594-555, 2009.
23. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: A 10 year prospective study. J Exp Allergy 33:206-210, 2003. (Pubitemid 36241378)
24. Marogna M, Spadolini I, Massolo A, et al. Long term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol 102:69-75, 2009.
25. Akdis M, and Akdis CA. Mechanisms of allergen specific immunotherapy. J Allergy Clin Immunol 119:780-791, 2007.
26. Rank MA, and James TCL. Allergen immunotherapy. Mayo Clin Proc 82:1119-1123, 2007.
27. Global Initiative for Asthma. Global strategy for asthma management and prevention. National Heart, Lung, and Blood Institute/World Health Organization (NHLBI/WHO) Workshop Report, NIH Publication 02-3659, NHLBI, Bethesda, MD, 2002.
28. Dykeewicz M, Fineman S, Skoner D, et al. Diagnosis and management of rhinitis. Complete guidelines of the joint task fore on practice parameters in allergy, asthma, and immunology. Ann Allergy Asthma Immunol 81:478, 1998.
29. Jenkins MA, Hopper JL, Flander LB, et al. The associations between childhood asthma and asthma and atopy, and parental asthma, hay fever and smoking. Paediatr Perinat Epidemiol 7:67-76, 1999.
30. Settipane RJ, Hagy GW, and Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Proc 15:21-25, 1994. (Pubitemid 2050501)
31. Fireman P. Rhinitis and asthma connection: Management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 21:45-54, 2000.
32. Togias A. Mechanisms of nose-lung interaction. Allergy 54(suppl 57):94-105, 1999.
33. Shen HH, Zhang GS, and Wang PL. Mycobacterium bovis bacillus Calmette-Guerin and asthma. Chin Med J 118:942-947, 2005.
34. Pederson PA, and Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy 38:25-29, 1983.
35. Larche M, Akdis CA, and Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6:761-771, 2006.
36. Justica JL, Barasona MJ, Serrano P, et al. Predicting patients at high risk of systemic reactions to cluster allergen immunotherapy: A pilot prospective observational study. J Investig Allergol Clin Immunol 17:386-392, 2006. (Pubitemid 350232563)
37. Brockow K, Kiehn M, Riethmuller C, et al. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo controlled trial. J Allergy Clin Immunol 10:458-463, 1997.
38. Rank MA, Oslie CL, Krogman JL, et al. Allergen immunotherapy safety: Characterizing systemic reactions and identifying risk factors. Allergy Asthma Proc 29:400-405, 2008.
39. Serrano P, Justica JL, Sanchez C, et al. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using a clustered regimens: A retrospective, observational multicentre study. Ann Allergy Asthma Immunol 102:247-252, 2009.
40. Malling HJ and Bousquet J. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin Allergy Immunol 21:343-358, 2008.
41. The Childhood Asthma Management Programme Research Group. Long term effects of budesonide or nodocromil in children with asthma. N Eng J Med 343:1054-1063, 2000.
42. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long term inhaled corticosteroids in preschool children at high risk for asthma. N Eng J Med 354:1985-1997, 2006.
43. Des RA, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides peteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99:450-453, 1997.
44. Jacobsen L, and Valovirta E. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? Curr Opin Allergy Clin Immunol 7:556-560, 2007.
45. Frew A. Immunotherapy of allergic disease. J Allergy Clin Immunol 111(suppl 2):S712-S719, 2003.
46. Rank M, and James TC. Allergen immunotherapy. Mayo Clin Proc 82:1119-1123, 2007.
47. Abramson M, Puy R, and Weiner J. Allergen immunotherapy for asthma. Cochrane Database System Rev 4:CD001186, 2003.
48. Abramson M, Puy R, and Weiner J. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trial. Am J Respir Crit Care Med 151:969-974, 1995.
49. Abramson M, Puy R, and Weiner J. Immunotherapy in asthma: An updated systematic review. Allergy 54:1022-1041, 1999. (Pubitemid 29482002)
50. Eng P, Reinhold M, and Gnehm H. Long-term efficacy of preseasonal grass pollen Immunotherapy in children. Allergy 57: 306-312, 2002. (Pubitemid 34280657)
51. Pajno GB, Barberio G, de Luca F, et al. Prevention of new sensitization in asthmatic children monosensitized to house dust mite by specific Immunotherapy: A six-year follow-up study. Clin Exp Allergy 31:1392-1397, 2001. (Pubitemid 32823876)
52. Boulay ME, and Boulet LP. Influence of natural exposure to pollens and domestic animals on airway responsiveness and inflammation in sensitized non-asthmatic subjects. Int Arch Allergy Immunol 128:336-343, 2002.